Skip to main content
Year archive

PharmAbcine Inc. — 2023 filings

All 103 regulatory filings released by PharmAbcine Inc. (208340) in 2023, sourced directly from the official regulator.

103 Filings
2023 Period
2023 filings (103)
Filing Released Lang
[기재정정]신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득(제2회차)
Capital/Financing Update
2023-12-28 Korean
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득
Capital/Financing Update
2023-12-27 Korean
불성실공시법인지정예고(공시번복)
Regulatory Filings
2023-12-27 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-12-26 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2023-12-26 Korean
최대주주변경
Major Shareholding Notification
2023-12-26 Korean
주주총회소집결의(임시주주총회)
AGM Information
2023-12-20 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-20 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-12-18 Korean
경영권변경등에관한계약체결
M&A Activity
2023-12-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-15 Korean
[기재정정]분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-12-13 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-12-08 Korean
투자판단관련주요경영사항([국책과제 선정]first in class tie2 activator PMC-403의 연령관련 황반변성 환자대상 임상 1상 연구)
Regulatory Filings
2023-12-05 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-12-01 Korean
기타주요경영사항(제3자배정 유상증자 철회)
Share Issue/Capital Change
2023-12-01 Korean
투자판단관련주요경영사항(경영지배인 해임의 건)
Board/Management Information
2023-11-30 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information
2023-11-27 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information
2023-11-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-11-23 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-11-23 Korean
최대주주변경
Major Shareholding Notification
2023-11-17 Korean
[기재정정]분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-16 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-11-13 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-11-13 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-11-10 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-11-10 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-11-10 Korean
불성실공시법인지정(공시불이행 1건,공시번복 1건)
Regulatory Filings
2023-11-02 Korean
주권매매거래정지(불성실공시법인 지정)
Delisting Announcement
2023-11-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-10-30 Korean
최대주주변경
Major Shareholding Notification
2023-10-30 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-10-27 Korean
단기차입금증가결정
Capital/Financing Update
2023-10-26 Korean
투자판단관련주요경영사항(경영지배인 선임의 건)
Board/Management Information
2023-10-26 Korean
주주총회소집결의(임시주주총회)
AGM Information
2023-10-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-10-26 Korean
소송등의판결ㆍ결정
Legal Proceedings Report
2023-10-24 Korean
불성실공시법인지정예고(공시불이행 1건, 공시번복 1건)
Regulatory Filings
2023-10-10 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-10-04 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2023-09-18 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2023-09-18 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2023-09-18 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-09-18 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information
2023-09-18 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정)(진행성 또는 전이성 고형암 환자에서 PMC-309(Anti-VISTA)의 안전성, 내약성 및 약동학을 평가하기 위한 최초 인간 투여, 공개 1a/1b상 임상시험계획 승인(HREC))
Legal Proceedings Report
2023-09-15 Korean
소송등의제기ㆍ신청(경영권분쟁소송)(주주총회소집허가)
Legal Proceedings Report
2023-09-15 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information
2023-09-15 Korean
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득
Capital/Financing Update
2023-09-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-09-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]소액공모실적보고서
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change
2023-09-11 Korean
최대주주변경을수반하는주식양수도계약해제ㆍ취소등
M&A Activity
2023-09-11 Korean
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득
Capital/Financing Update
2023-09-01 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2023-08-31 Korean
소액공모실적보고서
Share Issue/Capital Change
2023-08-31 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2023-08-25 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information
2023-08-25 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change
2023-08-24 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-08-24 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-08-17 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change
2023-08-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-08-14 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-08-07 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information
2023-08-07 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2023-08-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-08-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-08-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-08-02 Korean
[기재정정]최대주주변경
Major Shareholding Notification
2023-07-27 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-07-26 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-07-26 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-07-26 Korean
최대주주변경
Major Shareholding Notification
2023-07-26 Korean
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득
Capital/Financing Update
2023-07-24 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-07-07 Korean
[기재정정]소액공모공시서류(지분증권)
Capital/Financing Update
2023-07-07 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-06-29 Korean
유상증자최종발행가액확정
Capital/Financing Update
2023-06-29 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change
2023-06-29 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-06-26 Korean
소액공모공시서류(지분증권)
Share Issue/Capital Change
2023-06-26 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(진행성 또는 전이성 고형암 환자에서 PMC-309(Anti-VISTA)의 안전성, 내약성 및 약동학을 평가하기 위한 1a/1b상 임상시험계획 승인신청(HREC))
Regulatory Filings
2023-06-21 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-06-16 Korean
주주총회소집결의(임시주주총회)
AGM Information
2023-06-16 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2023-06-16 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정)(신생혈관성 연령관련 황반변성 환자를 대상으로 PMC-403 단회 및 반복 투여 용량 증량의 안전성 및 내약성을 평가하기 위한 다기관, 공개, 제 1상 임상시험계획 승인)
Regulatory Filings
2023-05-22 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-03-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-23 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-15 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-02-28 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-02-28 Korean
투자판단관련주요경영사항(재발성 교모세포종 환자를 대상으로 Pembrolizumab과 TTAC-0001 병용요법의 안전성 및 내약성을 평가하기 위한 공개, 제 1b 임상시험결과)
Legal Proceedings Report
2023-02-24 Korean
투자판단관련주요경영사항(전이성 삼중음성 유방암 환자를 대상으로 Pembrolizumab과 TTAC-0001 병용요법의 안전성 및 내약성을 평가하기 위한 공개, 제 1b 임상시험)
Legal Proceedings Report
2023-02-24 Korean
주주총회소집결의
AGM Information
2023-02-21 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-01-30 Korean